A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies
NCT07316907
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Hematologic Malignancies
Lymphoma
Interventions
BIOLOGICAL:
19UCART injection
Sponsor
YANRU WANG
Collaborators
[object Object]